Don't want to miss the best from Business Standard?
Wednesday, December 03, 2025 | 10:16 PM ISTहिंदी में पढें
Drug companies move Delhi HC seeking interim relief against FDC ban
The Union Ministry of Health and Family Welfare had on August 22 issued notification banning the 156 FDC medicines saying they had no therapeutic benefits
 "Drug, Medicine, Medical")
premium
The firms have sought an interim relief so that no coercive action is taken against stockists and retailers until the current stock of prohibited FDCs is exhausted. (Photo: Shutterstock)
A clutch of pharmaceutical companies approached the Delhi High Court on Thursday seeking interim relief against the central government’s decision to ban 156 fixed drug combination (FDC) medicines, so that they could clear the stocks lying in the market.
The Union Ministry of Health and Family Welfare had on August 22 issued notification banning the 156 FDC medicines saying they had no therapeutic benefits.
The high court, after admitting the petition, sought the government’s response by September 2.
FDCs are drugs that contain a combination of two or more active pharmaceutical ingredients (APIs) in a single form, usually manufactured and
